Literature DB >> 25942310

Kinetics of Antibodies Against Adalimumab Are Not Associated With Poor Outcomes in IBD.

S Paul1, W Dronne2, X Roblin2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25942310     DOI： 10.1038/ajg.2015.79

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

Review 1.  Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: a systematic review and meta-analysis.

Authors:  Uri Kopylov; Talal Al-Taweel; Mohammad Yaghoobi; Benedicte Nauche; Alain Bitton; Peter L Lakatos; Shomron Ben-Horin; Waqqas Afif; Ernest G Seidman
Journal:  J Crohns Colitis       Date:  2014-07-25       Impact factor: 9.071

2.  Antibody response to infliximab and its impact on pharmacokinetics can be transient.

Authors:  Niels Vande Casteele; Ann Gils; Sharat Singh; Linda Ohrmund; Scott Hauenstein; Paul Rutgeerts; Séverine Vermeire
Journal:  Am J Gastroenterol       Date:  2013-02-19       Impact factor: 10.864

3.  The temporal evolution of antidrug antibodies in patients with inflammatory bowel disease treated with infliximab.

Authors:  Bella Ungar; Yehuda Chowers; Miri Yavzori; Orit Picard; Ella Fudim; Ofir Har-Noy; Uri Kopylov; Rami Eliakim; Shomron Ben-Horin
Journal:  Gut       Date:  2013-09-16       Impact factor: 23.059
  3 in total
  4 in total

1.  Response to Steenholdt.

Authors:  S Paul; Xavier Roblin
Journal:  Am J Gastroenterol       Date:  2015-11       Impact factor: 10.864

2.  Transient and Persistent Antibodies Against TNF-Inhibitors in IBD.

Authors:  Casper Steenholdt
Journal:  Am J Gastroenterol       Date:  2015-11       Impact factor: 10.864

Review 3.  Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.

Authors:  Pieter Hindryckx; Gregor Novak; Niels Vande Casteele; Reena Khanna; Debby Laukens; Vipul Jairath; Brian G Feagan
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

4.  Relationship between clinical remission of perianal fistulas in Crohn's disease and serum adalimumab concentrations: A multi-center cross-sectional study.

Authors:  Laura Sirmai; Anne-Laure Pelletier; Nathalie Gault; Camille Zallot; Guillaume Bouguen; Dominique Bouchard; Pascale Roland Nicaise; Marine Peyneau; Sandrine Sironneau; Marcelo De Carvalho Bittencourt; Antoine Petitcollin; Pedro Fernandez; Xavier Roblin; Laurent Siproudhis; Laurent Abramowitz
Journal:  World J Gastroenterol       Date:  2022-03-07       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.